Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 22 tags : Pharm-country save search
Harmony Biosciences Appoints Linda Szyper To Its Board Of Directors
Published: 2021-11-22 (Crawled : 23:00) - biospace.com/
HRMY | $29.205 1.23% 1.22% 370K
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: -4.27%
bioscience
Scopus BioPharma Announces $9.75 Million Private Placement Priced At-The-Market
Published: 2021-11-22 (Crawled : 16:00) - biospace.com/
SCPS | $0.1682
|
|
| O: -0.16%
H: 0.0%
C: -11.54%
biopharma
Schrödinger to Participate in Five Upcoming Investor Conferences
Published: 2021-11-22 (Crawled : 14:00) - biospace.com/
SDGR | $24.04 -3.1% -3.2% 570K
|
Technology Services
|
| O: -0.82%
H: 0.1%
C: -6.28%
conference
Thorne HealthTech to Present at 4th Annual Evercore ISI HealthCONx Conference
Published: 2021-11-22 (Crawled : 14:00) - biospace.com/
THRN | $10.19 0.1% 85K
|
|
| O: 1.14%
H: 2.13%
C: -3.27%
conference
Athenex to Present Subgroup Analysis from Phase 3 Study of Oral Paclitaxel Plus Encequidar (KX-ORAX-001) in Metastatic Breast Cancer at SABCS 2021
Published: 2021-11-22 (Crawled : 14:00) - biospace.com/
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: 4.0%
H: 0.0%
C: -3.08%
cancer phase 3 breast cancer metastatic breast cancer
Marinus Pharmaceuticals Announces Nine Presentations and Virtual Investor Event at American Epilepsy Society 2021 Annual Meeting
Published: 2021-11-22 (Crawled : 13:00) - biospace.com/
MRNS | $1.44 0.0% 1.5M
|
Health Technology
|
| O: 1.16%
H: 0.49%
C: -1.72%
presentation
Organon To Present at the Evercore ISI 4th Annual HealthCONx Conference
Published: 2021-11-22 (Crawled : 13:00) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: 0.0%
conference
Provention Bio Provides Regulatory Update for Teplizumab At-Risk Type 1 Diabetes Approval Pathway
Published: 2021-11-22 (Crawled : 13:00) - biospace.com/
PRVB | $24.98 0.08% 9.1M
|
Health Technology
|
| O: 12.19%
H: 7.52%
C: 0.0%
diabetes risk approval teplizumab
Elucida Oncology Appoints Ian Somaiya as Chief Financial Officer and Chief Business Officer
Published: 2021-11-22 (Crawled : 13:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: 2.47%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.